The UK-based biotechnology company Freeline recently announced that the first U.S. patient has been dosed in its Phase 1/2 B-LIEVE dose-confirmation clinical trial of FLT180a for the treatment of hemophilia B. FLT180a is developed with the company’s…
In advance of World Hemophilia Day this year (April 17), NHF sat down with historian Dr. Helen Rappaport to learn more about how hemophilia impacted the Romanov family, and its lasting impact on world history. Read the interview transcript,…
FOR IMMEDIATE RELEASE
Media Contact:
Ilana Ostrin
iostrin@hemophilia.org
212-328-3769
April 17, 2022
STATEMENT FROM DR. LEONARD A. VALENTINO (NHF CEO) ON WORLD HEMOPHILIA DAY
On World Hemophilia Day…
NHF Announces Spring Webinar Lineup
Webinars occur on Wednesdays at 2 p.m. Eastern and are broadcast live
April 1, 2022
New York, NY--The National Hemophilia Foundation (NHF) is pleased to announce its upcoming lineup in the Wednesday…
National Hemophilia Foundation (NHF) Research Journal Club (RJC) April 2022: Dynamics of Hemarthrosis & Vascular Remodeling: Long-term impact of hypertension and joint bleeds for People Living with HemophiliaJoin Dr. von…
A group of investigators are embarking on a new research program designed to unpack some of the outstanding fundamental questions associated with current approaches to gene therapy for hemophilia A. While multiple gene therapies are currently in…
This Fly-Fishing Clinic is designed for anyone new to the sport of fly fishing, you want to improve your time on the water, need a little refresher, or you just want to spend some one-on-one time with experts. Space is limited to 25 fishers so…
Join Backpacks + Bleeders as we take on a new adventure – rock climbing at the Garden of the Gods! Grab your climbing shoes (tennis shoes, chacos, etc) and join us in Colorado Springs for this outdoor climb! Climbers age 7+ (with an accompanying…